Is the Compulsory Licensing Mechanism Guaranteed by TRIPS the Best Remedy to Improve Access to Biological Therapies Worldwide?. EEJTR 2019, 3 (1), 39-52. https://doi.org/10.15290/eejtr.2019.03.01.03.